News

Dana Boucher found relief with LUTATHERA, a targeted radioactive therapy specifically for neuroendocrine tumors (NETs) found in the gut or pancreas.

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

Saint Luke’s Sleep Disorders Program is a comprehensive, full-service program diagnosing and treating a wide variety of sleep disorders for more than 35 years.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

Over the years, they have done everything together: graduated high school, tied the knot, bought their first home, and raised a family. For all they have shared, they never dreamed of sharing a cancer diagnosis.